Practice Location

4383 MEDICAL DR
SAN ANTONIO, TX 78229-3307

Phone: (210) 593-5700

What does AMITA PATNAIK research?

Dr. Patnaik studies advanced cancer treatments, particularly focusing on drugs targeting specific mutations like KRAS G12C and therapies for challenging cancers such as non-Hodgkin lymphoma and prostate cancer. She also investigates new imaging techniques to improve surgical outcomes and explores immune cell behavior in tumors to refine cancer therapies. In addition to her cancer research, she looks at maternal health improvements in India and how to better manage tuberculosis in patients with HIV.

Key findings

  • Olomorasib caused tumor shrinkage in 195 patients, especially effective in non-colorectal cancers and those with brain metastases.
  • In the OPN-2853 trial, two patients experienced a complete cancer response lasting 18 months, indicating significant therapeutic potential.
  • Dynamic MRI improved recovery rates from surgery for degenerative cervical myelopathy by 8.6% compared to static MRI.
  • A study revealed that a new peptide could effectively kill prostate cancer cells, showing a promising new treatment avenue.
  • Jharkhand reduced its maternal mortality ratio from 371 to 56 deaths per 100,000 live births, highlighting successful healthcare improvements.

Frequently asked questions

Does Dr. Patnaik study cancer treatments?
Yes, Dr. Patnaik focuses on developing and testing new cancer therapies for several types of cancer, particularly those involving specific genetic mutations.
What conditions are addressed in Dr. Patnaik's research?
Her research addresses various conditions including advanced solid tumors, non-Hodgkin lymphoma, prostate cancer, and osteoporosis, among others.
Is Dr. Patnaik's work relevant to patients with degenerative cervical myelopathy?
Yes, her research on dynamic MRI techniques aims to improve surgical outcomes for patients suffering from degenerative cervical myelopathy.
What impact has Dr. Patnaik's research had on maternal health?
Her work has significantly contributed to understanding how maternal health can be improved, resulting in a notable decrease in maternal mortality in Jharkhand, India.
How does Dr. Patnaik's research help HIV patients?
She investigates tuberculosis care for adults living with HIV to enhance preventive treatment and improve overall health outcomes.

Publications in plain English

A novel peptide explicitly induces prostate cancer cell death by destabilizing AR and inhibiting AR-mediated transcription.

2026

Biochemical pharmacology

Agarwal A, Patnaik A, Gupta E, Jaiswal B, Gupta A

Plain English
This study looked at a new peptide designed to kill prostate cancer cells by disrupting the way these cells use the androgen receptor (AR), which is crucial for their growth. The researchers found that this peptide not only caused AR-positive cancer cells to die but also blocked AR activity in various ways, reducing cancer growth. This is important because it provides a potential new treatment option for patients whose cancer has become resistant to existing therapies. Who this helps: This helps patients with resistant prostate cancer.

PubMed

Implementation of tuberculosis care cascade among adult people living with HIV registered in anti-retroviral therapy centres in Odisha, India, 2020-2023.

2026

BMC infectious diseases

Patnaik A, Bhatnagar T, Das M, Arvind DS, Siya PK +8 more

Plain English
This study looked at how well tuberculosis (TB) care was provided to adults living with HIV in Odisha, India, from 2020 to 2023. Out of nearly 4,800 newly registered HIV patients, only 19% had data on TB screening; of those screened, 18.4% had symptoms suggesting TB, and only 64.2% of those eligible began preventive treatment. This matters because, although most who were screened received TB care, many missed out on preventive treatment, indicating gaps in the health system that need to be fixed. Who this helps: This helps patients living with HIV and healthcare providers.

PubMed

Utility of Dynamic MRI in Surgical Outcome of Patients With Degenerative Cervical Myelopathy: A Single-Center, Randomized Controlled Trial.

2026

Neurosurgery

Ajem A, Sekar A, Naik S, Bansal S, Jain M +2 more

Plain English
This study looked at how dynamic MRI (dMRI) could improve surgery outcomes for patients with degenerative cervical myelopathy (DCM). It found that patients who had surgery planned with dMRI had a better recovery rate of 55.4% compared to 46.8% for those who only had static MRI, and 91.9% of dMRI patients saw a recovery of at least 50% versus 59.4% in the static group. This matters because better imaging can lead to more effective surgeries and improved recovery for patients with this condition. Who this helps: Patients with degenerative cervical myelopathy.

PubMed

A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data.

2026

Journal of chemical information and modeling

MacDermott-Opeskin H, Scheen J, Wognum C, Horton JT, West D +121 more

Plain English
The study focused on a global challenge that aimed to improve how drugs are discovered for coronaviruses, specifically SARS-CoV-2 and MERS-CoV. Participants used advanced computer methods to predict how well small molecules could fight these viruses, analyzing data from a major research initiative. The results showed a variety of approaches, with specific strategies highlighted as particularly effective, which is important for developing reliable treatments quickly. Who this helps: This helps researchers and drug developers working on coronavirus treatments.

PubMed

Integrated Single-Cell Profiling Reveals Dichotomous NK Cell Populations Associated with Immunosuppression in Solid Tumors.

2026

Cancer immunology research

Lozada JR, Ali A, Luo C, Plagens RN, Zhang B +10 more

Plain English
This study looked at how different types of natural killer (NK) cells in tumors behave and how they affect cancer outcomes. Researchers found two main groups of NK cells: one that suppresses the immune response and one that boosts it. Specifically, the suppressive NK cells produced a signaling molecule called TGFB1, which can reduce the activity of other immune cells, while the pro-inflammatory NK cells produced IFNG and were linked to better survival in patients. This finding is important because understanding these different NK cell types can help improve cancer treatments and patient responses to therapies. Who this helps: This helps patients with solid tumors by informing treatment strategies.

PubMed

BET inhibitor OPN-2853 in advanced solid tumors and lymphoma: results from the phase 1b PLX124-01 trial.

2026

Cancer chemotherapy and pharmacology

Gordon MS, Carvajal RD, Spira A, Huang M, Inokuchi K +5 more

Plain English
This study tested a new drug called OPN-2853, which targets certain cancer proteins, in patients with advanced cancers like solid tumors and non-Hodgkin lymphoma. Researchers found that the best dose to give was 80 mg taken once a day, and while most patients reported mild side effects like nausea and fatigue, two patients showed significant improvement in their cancer, with one experiencing a complete response lasting 18 months. This matters because it shows that OPN-2853 is safe at this dose and may help some patients with difficult-to-treat cancers. Who this helps: Patients with advanced solid tumors and non-Hodgkin lymphoma.

PubMed

Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study.

2026

Nature communications

Murciano-Goroff YR, Hollebecque A, Heist RS, Cassier PA, Han JY +22 more

Plain English
This study looked at a new drug called olomorasib, which targets a specific mutation (KRAS G12C) in various advanced cancers. They tested 195 patients and found that the best dose was 150 mg taken twice a day, with few side effects reported. Overall, the drug showed promising results in shrinking tumors, especially in non-colorectal cancers, and it worked in some patients with brain metastases. Who this helps: This helps cancer patients with KRAS G12C mutations, particularly those with lung cancer or brain metastases.

PubMed

Decoding the significance of TERT gene in Polycystic Ovary Syndrome: From molecular mechanisms to emerging diagnostic and therapeutic strategies.

2026

Journal of ovarian research

Balgote PJ, Nowshad F, Patnaik A, Sivaraman J

PubMed

3 months vs 12 months of romosozumab for postmenopausal osteoporosis (LIDA): an open-label, non-inferiority, randomised controlled trial.

2026

The lancet. Diabetes & endocrinology

Leder BZ, Ramchand SK, Jordan M, Ryan S, Patnaik A +2 more

Plain English
This study looked at whether a shorter treatment of 3 months of a medication called romosozumab followed by 9 months of another drug, denosumab, is just as effective as a full 12 months of romosozumab for postmenopausal women with weak bones at high risk of fractures. The findings showed that both treatment plans resulted in similar increases in bone density in the hip: 5.7% for the 3-month group and 6.0% for the 12-month group, confirming that the shorter treatment is just as effective. This is important because it could make the treatment more accessible and less burdensome for patients, given the high cost and inconvenience of regular injections. Who this helps: This helps postmenopausal women at high risk of fractures who need effective osteoporosis treatment.

PubMed

Clinical, Microbiological Profile, and Treatment Response to Intraventricular Antibiotics in the Management of Postneurosurgical Meningitis: A Single-Center Experience.

2025

Journal of neurological surgery. Part A, Central European neurosurgery

Datta D, Sekar A, Pasha A, Patnaik A, Sahu RN +1 more

Plain English
This study looked at the treatment of serious infections called postneurosurgical meningitis in 26 patients who received antibiotics directly into their brain's fluid space. The researchers found that while the treatment helped improve the infection markers in most patients, sadly, three patients still died from the condition. This is important because it shows that giving antibiotics directly into the brain can be a useful option for patients who don't respond well to regular antibiotic treatments. Who this helps: This helps patients suffering from postneurosurgical meningitis and their doctors.

PubMed

A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies.

2025

Clinical cancer research : an official journal of the American Association for Cancer Research

Piha-Paul S, Olwill SA, Hamilton E, Tolcher A, Pohlmann P +16 more

Plain English
This study looked at a new cancer treatment called cinrebafusp alfa for patients with advanced cancers that are HER2-positive, which means their tumors have a specific protein that can be targeted. Out of 40 patients, 5 showed positive responses to the treatment, leading to an overall response rate of 12.5% and a disease-control rate of 52.5%. The treatment was safe to use with manageable side effects, and it could provide hope for patients who haven't responded to existing therapies targeting HER2. Who this helps: Patients with HER2-positive cancers who need new treatment options.

PubMed

Evolution of light-dependent functions of GIGANTEA.

2025

Journal of experimental botany

Patnaik A, Mishra P, Dash A, Panigrahy M, Panigrahi KCS

Plain English
This paper examines a protein called GIGANTEA (GI) found in plants, which plays important roles in many functions, like controlling the circadian clock and helping plants respond to light and stress. It was found that GI has evolved over time, integrating into various plant processes and acquiring new functions related to how plants manage light and make pigments. Understanding GI's evolution and how it works is important because it can help improve how plants grow and respond to their environment. Who this helps: This research benefits plant scientists and agricultural researchers who aim to enhance crop resilience and productivity.

PubMed

Genes encoding antibiotic modifying enzymes conferring resistance against aminoglycosides in bacteria: Their identification and detection from wastewater.

2025

Gene

Patnaik A, Kumar Rai S, Kumar Dhaked R

Plain English
This study examined how certain bacteria in wastewater are becoming resistant to aminoglycoside antibiotics, which are commonly used to treat infections. Researchers identified five specific genes responsible for this resistance and found two of these genes, npmA and sat4, in sewage samples from urban areas in Gwalior, India, showing the widespread issue of antibiotic resistance in polluted water. Understanding these resistance genes is important because it helps assess potential public health risks related to antibiotic-resistant infections. Who this helps: This helps healthcare providers and public health officials in managing and preventing antibiotic resistance.

PubMed

CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumours.

2025

BJC reports

Hecht JR, Michot JM, Bajor D, Patnaik A, Chung KY +15 more

Plain English
The CITRINO study looked at a new treatment called encelimab, which blocks a cancer-fighting protein (LAG-3), alone and with another treatment called dostarlimab in patients with advanced solid tumors. They tested different doses and found that while the treatments were generally safe, only a few patients saw positive results—3% responded in one group and 17% in another. This matters because it helps researchers understand how to combine these therapies to improve their effectiveness for treating difficult cancers. Who this helps: This helps patients with advanced solid tumors and their doctors in exploring new treatment options.

PubMed

Seroprevalence of melioidosis and its associated risk factors -A population-based study in Odisha, Eastern India.

2025

Current research in microbial sciences

Behera B, Singh AK, Ahmad M, Rout L, Jena J +11 more

Plain English
This study looked at the presence of melioidosis, a serious disease in Odisha, India, by testing blood samples from 1,920 people aged 5 to 60. They found that 410 people, or 20.9%, showed signs of past infection, with younger adults (ages 21-30) and women showing higher rates. The disease is more common in rural areas, particularly among those who work with soil or near water, highlighting the need for better public health measures to raise awareness and reduce risks. Who this helps: This helps patients in rural areas and public health officials.

PubMed

PIDA-mediated synthesis of kynurenine derivatives by oxidative fragmentation of the tryptophan scaffold.

2025

Organic & biomolecular chemistry

Jena CK, Patnaik A, Nayak SS, Kumari S, Panda A +2 more

Plain English
This study looked at how to create special compounds called kynurenine derivatives from a protein building block called tryptophan. Researchers found that using a particular chemical method, they could produce these kynurenine derivatives effectively. In tests, certain kynurenine derivatives were able to stop the growth of antibiotic-resistant bacteria by disrupting their communication, which is a significant finding as it suggests a new way to fight stubborn infections. Who this helps: This benefits doctors and patients dealing with antibiotic-resistant bacterial infections.

PubMed

Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer.

2025

Journal for immunotherapy of cancer

Yeku OO, Barve M, Tan WW, Wang J, Patnaik A +12 more

Plain English
This study looked at two new antibody treatments, PY159 and PY314, for patients with platinum-resistant ovarian cancer. In their trials, 50% of patients on each treatment maintained stable disease for an average of about 13 weeks, with the treatments showing good safety profiles. This research is important because it introduces potential new therapies for patients who have limited options left after multiple prior treatments. Who this helps: This helps patients with platinum-resistant ovarian cancer who need better treatment options.

PubMed

Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis.

2025

Molecular cancer research : MCR

Mei S, Zhang H, Hirz T, Jeffries NE, Xu Y +7 more

Plain English
Researchers studied a type of immune cell called tumor-associated macrophages (TAMs) in prostate cancer to understand their roles in tumor growth and spread. They discovered four different groups of TAMs, with one specific group marked by certain proteins (SPP1 and TREM2) being more common in metastatic tumors. This group was linked to worse survival for patients but targeting it could improve treatments, particularly those that help the immune system fight cancer. Who this helps: This helps patients with advanced prostate cancer and their doctors by identifying potential new treatment strategies.

PubMed

A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid Tumors.

2025

Targeted oncology

Eng C, Lakhani NJ, Philip PA, Schneider C, Johnson B +11 more

Plain English
This study looked at a new treatment combining the drug magrolimab with cetuximab for patients with advanced colorectal cancer and other solid tumors. Researchers found that while the combination was generally safe, it showed limited effectiveness: only 6.3% of patients with a specific type of colorectal cancer responded to the treatment, and the average survival for patients was around 9.5 months. These findings are significant as they highlight the need for better treatments for patients who have not responded to standard therapies. Who this helps: This research benefits patients with advanced colorectal cancer who are looking for new treatment options.

PubMed

Analytical techniques and molecular platforms for detection and surveillance of antimicrobial resistance: advancements of the past decade.

2025

3 Biotech

Patnaik A, Rai SK, Dhaked RK

Plain English
This research paper looks at the progress made over the past ten years in detecting and monitoring antibiotic resistance in bacteria. It highlights improvements in techniques that make it faster and more accurate to identify when bacteria are resistant to antibiotics, stressing the need for better diagnostic tools to prevent the misuse of antibiotics that can lead to dangerous infections. The paper mentions various advanced methods, showing that modern tools like CRISPR and new machines have made diagnosing drug resistance more effective. Who this helps: This benefits doctors and healthcare providers, leading to better treatment for patients with bacterial infections.

PubMed

Factors associated with nonuse of helmet among motorcyclists sustaining road traffic accidents.

2025

International journal of critical illness and injury science

Mishra A, Radhakrishnan RV, Patnaik A, Mohanty CR, Jain M +6 more

Plain English
This study looked at why many motorcyclists in Eastern India do not wear helmets, despite their importance for safety. Out of 346 motorcyclists involved in accidents, only 35.7% were wearing helmets, and not wearing one was linked to higher injury severity scores (average of 13.20 for nonusers compared to 11.23 for users). Factors such as riding short distances, forgetfulness, fewer traffic checkpoints, and alcohol abuse were commonly associated with not wearing helmets. Who this helps: This research benefits motorcyclists and public health officials by highlighting safety issues and potential areas for intervention.

PubMed

Effectiveness of Plan-Do-Check-Act approach in improving the safe injection practice among healthcare workers in a secondary-level healthcare facility - A pre- and post-study design.

2025

Journal of education and health promotion

Pal D, Patnaik A, Mishra A, Singh AK, Parida SP +1 more

Plain English
This study looked at how effective a method called Plan-Do-Check-Act (PDCA) was in improving safe injection practices among healthcare workers at a rural community health center in India. Before the training, unsafe practices were common, with issues ranging from 0% to 93% in different activities. After the PDCA training, there was a small improvement in practices, like the proper use of syringes, which increased from 85.37% to 88.11%. However, proper waste disposal didn’t show significant change. Who this helps: This benefits healthcare workers and patients receiving injections, ensuring safer medical practices.

PubMed

A mixed-method study to improve outcome of mass drug administration in two TAS failed districts of Uttar Pradesh, India.

2025

PLoS neglected tropical diseases

Srivatsa A, Biswal P, Routray S, Prasad S, Bardosh K +5 more

Plain English
This study looked at how to improve the participation of people in mass drug distribution campaigns aimed at fighting lymphatic filariasis (LF) in two districts of Uttar Pradesh, India. Researchers found that fears of side effects were the main reason people avoided taking the medication, along with issues like not being home or lacking awareness. After implementing a new intervention, drug consumption increased by 10.1% in Varanasi and 20.7% in Chitrakoot, while community awareness grew by 40% in Chitrakoot. Who this helps: This helps patients at risk of lymphatic filariasis and public health officials managing drug distribution efforts.

PubMed

Study of the association of Burkholderia pseudomallei lipopolysaccharide genotypes and variable virulence factors with different clinical manifestations of melioidosis.

2025

Indian journal of medical microbiology

Jena J, Behera B, Mohanty S, Mishra B, Mohapatra PR +1 more

Plain English
This study looked at different genetic types of the bacteria Burkholderia pseudomallei, which causes melioidosis, in 100 patients from a hospital in Eastern India. The researchers found that the most common genetic type was LPS A, making up 40% of the samples, while no connection was found between the genetic variations and patient outcomes. Understanding these genetic differences is important because it can help identify how the disease behaves in different regions, especially since India is a hotspot for melioidosis. Who this helps: This helps doctors and researchers working to treat and understand melioidosis better.

PubMed

Laser applications to chemical, security, and environmental analysis: introduction to the feature issue.

2025

Applied optics

Winters C, Farooq A, Jiang N, Arndt C, Sahlberg AL +1 more

Plain English
Researchers gathered in Toulouse, France, for a meeting focused on new ways to use lasers in areas like chemistry, security, and environmental monitoring. They shared 125 papers on various topics, including advanced techniques for analyzing substances and developing sensors. This research is important because it leads to better tools for detecting harmful chemicals and improving safety measures in our surroundings. Who this helps: This benefits scientists, environmental agencies, and safety professionals.

PubMed

Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes.

2025

Prostate cancer and prostatic diseases

Zorko NA, Makovec A, Elliott A, Kellen S, Lozada JR +19 more

PubMed

Clinical Outcomes and Patient-Reported Outcomes of Minimally Invasive Glaucoma Surgery Techniques Over the Past Decade.

2025

Cureus

Singh P, Sharma B, Sarma N, Nag DS, Patnaik A +1 more

Plain English
This study looked at how effective minimally invasive glaucoma surgeries (MIGS) have been over the last ten years in treating glaucoma. The findings showed that MIGS can lower eye pressure by 15-50%, reduce the need for glaucoma medications by about half a drug, and have low complication rates (less than 20% for bleeding and 15.4% for low eye pressure). This is important because it offers patients safer and more effective options compared to traditional surgery, leading to better overall health and quality of life. Who this helps: This benefits glaucoma patients and their eye doctors.

PubMed

A possible role for immunogenetic factors in myositis developing after vaccination in the pre-covid-19 era.

2025

Frontiers in immunology

Alhassan E, Patnaik A, Shamim EA, Pandey JP, Rider LG +1 more

Plain English
This study looked at how certain genetic factors might affect the risk of developing a rare autoimmune condition called myositis after vaccination. Researchers analyzed data from 56 patients who developed this condition, compared to 133 patients who had myositis but were not vaccinated recently, and 527 healthy people. They found that a specific genetic marker (HLA-DQA1*03:03) increased the risk of myositis after vaccination in Caucasian individuals by about four times, while another genetic marker provided protection against this condition. Who this helps: This research benefits patients who may experience vaccine-related complications, as it could lead to improved safety measures and individualized risk assessments.

PubMed

Bibliometric Analysis of Global Scientific Literature on Mumps Vaccines.

2025

Cureus

Tripathy D, Pal D, Pisudde PM, Taywade M, Patnaik A

Plain English
This study examined global research on mumps vaccines by analyzing 699 published articles from 1972 to 2021. It found that the average number of times these articles were cited is about 34, with a peak of 66 articles published in 2015. The research highlights key authors, journals, and trends, which helps identify areas where more work is needed, guiding future studies on mumps vaccines. Who this helps: This information benefits researchers and public health officials working to improve vaccine research and development.

PubMed

Longitudinal analysis of age-dependent phenotypes in hemizygous male and heterozygous female Cdkl5 mutant mice.

2025

Experimental neurology

Kannan AL, Patnaik A, Theurer A, Demuth L, Korte M +2 more

Plain English
This study looked at how a genetic mutation that affects the CDKL5 gene impacts mice over time, focusing on their brain development, behavior, and specific brain cell connections. The researchers found that both male and female mice with the mutation experience changes in brain function and behavior as they age, with these changes varying by age, brain region, and sex. This research is important because it helps us better understand the disorder linked to the CDKL5 mutation, which can lead to better treatments for people affected by similar conditions. Who this helps: Patients and their families dealing with CDKL5-related disorders.

PubMed

Tropone-Enabled Pd-Catalyzed C(sp)-H Functionalization of Phenylalanine: Switchable Access to Indoline and Olefinate.

2025

Organic letters

Nayak SS, Patnaik A, Jena CK, Sharma NK

Plain English
This study looked at a new method for transforming the amino acid phenylalanine into two different types of compounds—indoline and olefinate—using a specific catalyst. The research found that this process can be done selectively and works well with various chemical groups attached to phenylalanine. This is significant because it offers a flexible way to create diverse peptides, which could be valuable in developing new drugs or treatments. Who this helps: This benefits researchers and pharmaceutical companies working on new medications.

PubMed

Spatially organized lymphocytic microenvironments in high grade primary prostate tumors.

2025

bioRxiv : the preprint server for biology

Amiryousefi A, Wala J, Lin JR, Labadie BW, Atmakuri A +12 more

Plain English
This study looked at how immune cells are arranged in tumors from prostate cancer patients, especially focusing on those with high-grade tumors (14 patients) compared to low-grade ones (15 patients). The researchers found that high-grade tumors had a lot more immune cells that were grouped together in organized clusters, which might help the body fight the cancer. Specifically, these clusters in high-grade tumors were denser and mostly contained active T cells, indicating a potentially better immune response against the tumor. Who this helps: This helps patients with high-grade prostate cancer by identifying promising immune targets for future treatments.

PubMed

Unravelling Maternal Health Success of Jharkhand - A Potential Case Study for Positive Deviance.

2025

Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine

Patnaik A, Jena SK, Patro BK

Plain English
Researchers studied the improvements in maternal health in Jharkhand, India, noting that the state dramatically lowered its Maternal Mortality Ratio (MMR) from 371 to 56 deaths per 100,000 live births between 2011 and 2020. Despite this success, Jharkhand still needs to address its Total Fertility Rate (TFR) to meet national goals. The findings emphasize the importance of both medical care and social behavior changes to sustain maternal health advancements while also working on fertility rates. Who this helps: This benefits mothers in Jharkhand and health professionals working to improve maternal health outcomes.

PubMed

A 1-year study on SARS-CoV-2 variant shifts in wastewater using dPCR: comparison with clinical and GISAID data.

2025

mSystems

Mosavi SMR, Acer P, Andersen P, Barbero R, Barksdale S +58 more

Plain English
In this study, researchers looked at a new way to detect COVID-19 variants in wastewater, testing over 1,400 samples from six states between April 2023 and May 2024. They found that this new digital PCR method not only quickly identified emerging variants like EG.5 and FL before they showed up in clinical tests but also had a strong agreement with traditional sequencing methods, with a match rate of 62% to 98%. This is important because it allows public health officials to monitor the virus's evolution more efficiently and cost-effectively as clinical testing declines. Who this helps: This benefits public health officials and communities by providing timely information on COVID-19 variants.

PubMed

HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer.

2025

Prostate cancer and prostatic diseases

Likasitwatanakul P, Besonen C, Tsai AK, Sadeghipour N, Elliott A +12 more

Plain English
This research looked at how levels of a protein called HLA class I in prostate cancer tumors affect the immune environment around them and patient outcomes. By analyzing data from over 8,000 prostate cancer samples, the study found that tumors with high levels of HLA class I had more active immune responses and specific genetic characteristics. Notably, higher levels of certain HLA proteins were linked to shorter survival in patients, while one type, HLA-C, was associated with longer survival. Who this helps: This information can help doctors better understand which prostate cancer patients may have more aggressive disease and could guide treatment decisions.

PubMed

Development and Application of a Mind Map to Improve the Adolescent Behaviour on Mental Health and Substance Abuse in Rural Odisha: A Community-Based Quasi-experimental Study Design.

2025

Cureus

Roy P, Mishra A, Singh AK, Parida SP, Murmu N +1 more

Plain English
This study looked at how using mind maps could help improve mental health and reduce substance abuse among adolescents in rural Odisha, India. Researchers found that participants had a significant drop in mental health issues, measured by the PHQ-9 score, from an average of 7.06 to 5.78, and a decrease in substance involvement from 2.89 to 1.83 after using the mind maps. This is important because addressing these issues can lead to healthier lives for young people in these communities. Who this helps: This helps adolescents struggling with mental health and substance abuse issues.

PubMed

Environmental Degradation of Footbed Materials Under Different Conditions.

2025

Polymers

Patnaik A, Muniyasamy S, Goyal A

Plain English
This study examined how different footbed materials used in shoes, made from recycled polyester, hemp, and shoddy fibers, break down under various environmental conditions. It found that hemp starts to degrade after 120 hours of exposure, while recycled polyester takes about 360 hours, resulting in significant changes to the material. The research highlighted that the recycled polyester had the best strength and resistance to wear, with a tensile strength ranging from roughly 50 to 851 newtons. Understanding how these materials degrade helps in choosing more sustainable options for footwear. Who this helps: This benefits shoe manufacturers and environmentally conscious consumers.

PubMed

Neuropsychiatric Systemic Lupus Erythematosus: A Case Series.

2025

Cureus

Garcia-Smester MA, Patnaik A

Plain English
This study looked at three female patients with neuropsychiatric systemic lupus erythematosus (NPSLE), which causes various brain and mental health problems. The patients experienced different symptoms, including severe confusion, inflammation in the brain, and catatonia, and were treated with strong medications like corticosteroids and cyclophosphamide. The findings highlight the importance of quickly identifying NPSLE and tailoring treatment for better recovery, as no two cases are the same. Who this helps: This benefits patients with systemic lupus erythematosus and their doctors.

PubMed

Fc-Silent Anti-TIGIT Antibodies Potentiate Antitumor Immunity without Depleting Regulatory T Cells.

2024

Cancer research

Piovesan D, de Groot AE, Cho S, Anderson AE, Ray RD +12 more

Plain English
This study looked at two different types of antibodies designed to target a protein called TIGIT on immune cells, which can help improve the body’s ability to fight tumors. Researchers found that one type, called Fc-silent anti-TIGIT antibodies, boosted the activation of tumor-fighting immune cells without reducing the number of regulatory T cells, which usually help keep immune responses in check. This means Fc-silent antibodies could be a safer and more effective option for cancer treatment, maintaining essential immune balance while still promoting anti-tumor activity. Who this helps: This research benefits cancer patients by potentially offering new treatment options that harness the immune system more effectively.

PubMed

Effects on household income and earnings from chronic kidney disease of non-traditional origins: PREP project findings from Chichigalpa, Nicaragua.

2024

Occupational and environmental medicine

Prince H, Boswell T, Glaser J, Wesseling C, Patnaik A +1 more

Plain English
This study looked at how chronic kidney disease from unknown causes (CKDnt) affects household income in four sugarcane-growing communities in Chichigalpa, Nicaragua. They found that about one-third of the households had someone diagnosed with CKDnt, and those households were hit hard economically—86% of them had a household member out of work for over six months, while non-CKDnt households had less than half facing this situation. Despite CKDnt households bringing in less money overall, they received significant social security payments that helped boost their income above that of non-CKDnt households, highlighting a larger economic pressure on the government from these health issues. Who this helps: This research benefits policymakers and healthcare providers focused on supporting communities affected by chronic diseases.

PubMed

Genetic identification of medullary neurons underlying congenital hypoventilation.

2024

Science advances

Cui K, Xia Y, Patnaik A, Salivara A, Lowenstein ED +13 more

Plain English
This study focused on understanding specific neurons in the brainstem that are responsible for breathing issues in babies with congenital hypoventilation. Researchers discovered distinct groups of neurons that play important roles in controlling breath size, response to high carbon dioxide levels, and overall breathing stability and survival in newborns. Their findings help clarify how these neurons function, which is crucial for treating and managing respiratory disorders in affected infants. Who this helps: This helps patients with congenital hypoventilation and their doctors in understanding and addressing these breathing challenges.

PubMed

Impact of metamorphoses from desk to E-commute - an acumen of professionals: A cross-sectional study.

2024

Journal of family medicine and primary care

Patnaik A, Behera TR, Pradhan S, Mohapatra D, Mohanty S

Plain English
This study looked at how working from home during the COVID-19 pandemic changed the work patterns and quality of life for professionals. Out of 520 respondents, most worked long hours, especially men, with about 73% of them putting in over 12 hours a day, while the overall quality of life improved for many as their working hours decreased. The findings indicate that setting rules to support mental health and well-being could help workers become more efficient and satisfied. Who this helps: This helps professionals working from home and employers looking to improve workplace conditions.

PubMed

Effect of Surface Electron Trapping and Small Polaron Formation on the Photocatalytic Efficiency of Copper(I) and Copper(II) Oxides.

2024

ACS applied materials & interfaces

Bandaranayake S, Patnaik A, Hruska E, Zhu Q, Das S +1 more

Plain English
This study explored how the behavior of electrons on the surface of copper oxides, a type of material that can be used to generate energy from light, affects their efficiency in producing hydrogen. Researchers found that in materials with copper atom vacancies, electrons got trapped very quickly (in less than 0.1 billionths of a second), which reduced their ability to generate electricity. In contrast, in pure copper oxide, electrons behaved differently, taking about 0.5 billionths of a second to form stable structures that helped maintain efficiency. Who this helps: This research will benefit scientists and engineers working on improving energy generation technologies.

PubMed

High-density polyethylene microplastics in agricultural soil: Impact on microbes, enzymes, and carbon-nitrogen ratio.

2024

Journal of environmental quality

Moharana T, Patnaik A, Mishra CSK, Behera BP, Samal RR

Plain English
This study looked at how high-density polyethylene (HDPE) microplastics affect agricultural soil, specifically examining their impact on bacteria, fungi, and important soil enzymes. At varying concentrations of HDPE, researchers found that lower amounts reduced bacterial counts but increased them after 60 days, while fungus counts initially rose but then leveled out. Additionally, enzyme activity dropped as the amount of microplastics increased and the soil's carbon-to-nitrogen ratio became significantly higher, indicating slower decomposition of organic materials. Who this helps: This research helps farmers and environmental scientists understand how plastic pollution affects soil health and fertility.

PubMed

Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2).

2024

Journal for immunotherapy of cancer

Davar D, Cavalcante L, Lakhani N, Moser J, Millward M +15 more

Plain English
This research studied a new treatment called davoceticept (ALPN-202) for people with advanced solid tumors. The study found that while davoceticept alone and in combination with another drug, pembrolizumab, had some positive effects, it also led to serious side effects, including two deaths related to heart issues. Specifically, 67% of patients on davoceticept experienced treatment-related side effects, and the combination therapy resulted in a higher percentage of severe side effects. Who this helps: This information benefits patients with advanced solid tumors, particularly those considering new treatment options.

PubMed

Unmasking the Veiled Intruder: A Complicated Case of Eosinophilic Fasciitis.

2024

Cureus

Uddin A, Lozeau D, Patnaik A

Plain English
The study focuses on eosinophilic fasciitis (EF), a rare disease that causes skin and connective tissue thickening, but doesn't affect internal organs like some other conditions do. The researchers looked at a patient who had noticeable thickening of her skin on her arms and legs, leading to a diagnosis of EF confirmed by a skin biopsy. This highlights the need for healthcare providers to recognize the specific signs of EF for proper diagnosis and treatment. Who this helps: Patients with eosinophilic fasciitis and their doctors.

PubMed

Comparative Study of Degree of Great Toe Movement after Complete and Partial Flexor Hallucis Longus Harvest in Free Fibula Flap.

2024

Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India

Agnihotri I, Nayak BB, Lakhotia P, Patnaik A, Mohanty RR

Plain English
This study looked at how much people can move their big toe after having part or all of a specific muscle (the flexor hallucis longus) removed during surgery to reconstruct other parts of the body. The researchers found that patients who had only part of the muscle removed had better toe movement compared to those who had it completely taken out, with significant differences in their toe movement. This is important because it shows that doctors can often leave part of this muscle intact, which helps preserve toe movement without affecting the surgery's success. Who this helps: This benefits patients undergoing reconstructive surgery who wish to maintain better toe function.

PubMed

Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis.

2024

Leukemia research

McCall D, Abuasab T, Rodriguez-Sevilla JJ, Mohamed SF, Patnaik A +16 more

Plain English
This study looked at data from 119 children, adolescents, and young adults with myelodysplastic neoplasms (a type of blood disorder) treated at a single center between 2000 and 2022. They found that 36% of these patients had myelodysplastic neoplasms related to previous treatments, and 31% went on to develop acute myeloid leukemia. The overall survival rate after five years was 45%, and those who received a stem cell transplant lived longer on average; however, the type of initial treatment did not significantly change outcomes. Who this helps: This research benefits young patients with blood disorders and their doctors by highlighting treatment options and survival trends.

PubMed

An Assessment of Collaborations Between Centers for Independent Living and Vocational Rehabilitation Agencies Around Transition-Age Youth.

2024

Rehabilitation counselors and educators journal

Patnaik A, Honeycutt T

Plain English
This study looked at how Centers for Independent Living (CILs) and Vocational Rehabilitation (VR) agencies work together to support young people with disabilities transitioning into adulthood. Researchers found that while many CILs and VR agencies do collaborate, these partnerships only reach a small number of eligible youth; for instance, young people using CIL services often differ significantly from others seeking VR help. Enhancing collaboration could provide better support for these youth, highlighting the need for more research to see how these partnerships can be improved. Who this helps: This helps transition-age youth with disabilities.

PubMed

Reversible pH-responsive supramolecular aggregates from viologen based amphiphiles - a molecular design perspective.

2024

Soft matter

Narendran RL, Patnaik A

Plain English
This study explored how to create special water-based structures called supramolecular aggregates using a compound known as benzyl viologen. Researchers found that by adding a compound called β-cyclodextrin, they could improve the solubility of viologen and enable these structures to change behavior in response to pH levels. For example, the addition of β-cyclodextrin led to better dissolution and aggregation properties, making these systems more versatile for applications in technology and medicine. Who this helps: This benefits scientists and engineers working on drug delivery systems and other advanced materials.

PubMed

Frequent Co-Authors

Abhisek Mishra Andrew Elliott Nicholas A Zorko Emmanuel S Antonarakis Justin H Hwang Alexander Spira John R Lozada Elisabeth I Heath Jeffrey S Miller Arunkumar Sekar

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.